145 related articles for article (PubMed ID: 36918265)
21. ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer.
Sato T; Saito M; Nakajima S; Saito K; Katagata M; Fukai S; Okayama H; Sakamoto W; Saze Z; Momma T; Mimura K; Kono K
Gastric Cancer; 2023 May; 26(3):379-392. PubMed ID: 36811690
[TBL] [Abstract][Full Text] [Related]
22. Unique characteristics of
Kim YS; Jeong H; Choi JW; Oh HE; Lee JH
Saudi J Gastroenterol; 2017; 23(5):268-274. PubMed ID: 28937020
[TBL] [Abstract][Full Text] [Related]
23. Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer.
Wang X; Che K; Shi T; Liu Q; Xu X; Wu H; Yu L; Liu B; Wei J
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1583-1595. PubMed ID: 35294647
[TBL] [Abstract][Full Text] [Related]
24. ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.
Nagarajan S; Rao SV; Sutton J; Cheeseman D; Dunn S; Papachristou EK; Prada JG; Couturier DL; Kumar S; Kishore K; Chilamakuri CSR; Glont SE; Archer Goode E; Brodie C; Guppy N; Natrajan R; Bruna A; Caldas C; Russell A; Siersbæk R; Yusa K; Chernukhin I; Carroll JS
Nat Genet; 2020 Feb; 52(2):187-197. PubMed ID: 31913353
[TBL] [Abstract][Full Text] [Related]
25. Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency.
Han N; Kim MA; Lee HS; Kim WH
Appl Immunohistochem Mol Morphol; 2016; 24(5):320-5. PubMed ID: 26067140
[TBL] [Abstract][Full Text] [Related]
26. Potential therapeutic targets in ARID1A-mutated cancers.
Bitler BG; Fatkhutdinov N; Zhang R
Expert Opin Ther Targets; 2015; 19(11):1419-22. PubMed ID: 26125128
[TBL] [Abstract][Full Text] [Related]
27. ARID1A-mutated ovarian cancers depend on HDAC6 activity.
Bitler BG; Wu S; Park PH; Hai Y; Aird KM; Wang Y; Zhai Y; Kossenkov AV; Vara-Ailor A; Rauscher FJ; Zou W; Speicher DW; Huntsman DG; Conejo-Garcia JR; Cho KR; Christianson DW; Zhang R
Nat Cell Biol; 2017 Aug; 19(8):962-973. PubMed ID: 28737768
[TBL] [Abstract][Full Text] [Related]
28. ARID1A loss activates MAPK signaling via DUSP4 downregulation.
Mandal J; Yu ZC; Shih IM; Wang TL
J Biomed Sci; 2023 Dec; 30(1):94. PubMed ID: 38071325
[TBL] [Abstract][Full Text] [Related]
29. miR-7641 depletion suppresses proliferation of gastric cancer cells by targeting ARID1A.
Yang Y; Yin ZX; Wang ZY; Tian SB; Wang HC; Zhang FX; Li LP; Zheng C; Kong S
Anticancer Drugs; 2020 Apr; 31(4):368-376. PubMed ID: 31913196
[TBL] [Abstract][Full Text] [Related]
30. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
[TBL] [Abstract][Full Text] [Related]
31. Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting
Dong X; Song S; Li Y; Fan Y; Wang L; Wang R; Huo L; Scott A; Xu Y; Pizzi MP; Ma L; Wang Y; Jin J; Zhao W; Yao X; Johnson RL; Wang L; Wang Z; Peng G; Ajani JA
Gut; 2022 Mar; 71(3):467-478. PubMed ID: 33785559
[TBL] [Abstract][Full Text] [Related]
32. DNA damage regulates ARID1A stability via SCF ubiquitin ligase in gastric cancer cells.
Jiang ZH; Dong XW; Shen YC; Qian HL; Yan M; Yu ZH; He HB; Lu CD; Qiu F
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3194-200. PubMed ID: 26400522
[TBL] [Abstract][Full Text] [Related]
33. Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response.
Mandal J; Mandal P; Wang TL; Shih IM
J Biomed Sci; 2022 Sep; 29(1):71. PubMed ID: 36123603
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.
Lakshminarasimhan R; Andreu-Vieyra C; Lawrenson K; Duymich CE; Gayther SA; Liang G; Jones PA
Cancer Lett; 2017 Aug; 401():11-19. PubMed ID: 28483516
[TBL] [Abstract][Full Text] [Related]
35. ARID1A mutations in cancer development: mechanism and therapy.
Zhang X; Zhang Y; Zhao J; Wu Y; Zhang N; Shen W
Carcinogenesis; 2023 May; 44(3):197-208. PubMed ID: 36882165
[TBL] [Abstract][Full Text] [Related]
36. ARID1A loss in cancer: Towards a mechanistic understanding.
Mathur R
Pharmacol Ther; 2018 Oct; 190():15-23. PubMed ID: 29730444
[TBL] [Abstract][Full Text] [Related]
37. Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma.
Qamra A; Xing M; Padmanabhan N; Kwok JJT; Zhang S; Xu C; Leong YS; Lee Lim AP; Tang Q; Ooi WF; Suling Lin J; Nandi T; Yao X; Ong X; Lee M; Tay ST; Keng ATL; Gondo Santoso E; Ng CCY; Ng A; Jusakul A; Smoot D; Ashktorab H; Rha SY; Yeoh KG; Peng Yong W; Chow PKH; Chan WH; Ong HS; Soo KC; Kim KM; Wong WK; Rozen SG; Teh BT; Kappei D; Lee J; Connolly J; Tan P
Cancer Discov; 2017 Jun; 7(6):630-651. PubMed ID: 28320776
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of multiple parameters associated with tumor immune microenvironment in
Li Z; Lin J; Zhang L; Li J; Zhang Y; Zhao C; Wang H
Future Oncol; 2020 Oct; 16(29):2295-2306. PubMed ID: 32639175
[No Abstract] [Full Text] [Related]
39. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
[TBL] [Abstract][Full Text] [Related]
40. ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.
Shen J; Ju Z; Zhao W; Wang L; Peng Y; Ge Z; Nagel ZD; Zou J; Wang C; Kapoor P; Ma X; Ma D; Liang J; Song S; Liu J; Samson LD; Ajani JA; Li GM; Liang H; Shen X; Mills GB; Peng G
Nat Med; 2018 May; 24(5):556-562. PubMed ID: 29736026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
